Provided by Tiger Fintech (Singapore) Pte. Ltd.

Trevi Therapeutics, Inc.

6.58
-0.3200-4.64%
Volume:707.35K
Turnover:4.71M
Market Cap:636.17M
PE:-14.00
High:6.85
Open:6.80
Low:6.56
Close:6.90
Loading ...
Apr 08, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Apr 07, 2022

Major Issues Report

8-K - Current report
Mar 17, 2022

Major Issues Report

8-K - Current report
Mar 17, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 16, 2022

Major Issues Report

8-K - Current report
Mar 09, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Mar 09, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 24, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 01, 2022

Major Issues Report

8-K - Current report
Jan 26, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 14, 2022

Major Issues Report

8-K - Current report
Jan 05, 2022

Major Issues Report

8-K - Current report
Nov 12, 2021

Correspondence

CORRESP [Cover] - Correspondence
Nov 10, 2021

Major Issues Report

8-K - Current report
Nov 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 02, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Oct 21, 2021

Correspondence

CORRESP [Cover] - Correspondence
Oct 19, 2021

Major Issues Report

8-K - Current report